Valuation: BioNTech SE

Market Cap 20.22B 23.1B 18.67B 17.18B 32.39B 2,226B 33.11B 223B 87.61B 1,091B 86.74B 84.86B 3,755B P/E 2026 *
-18.2x
P/E 2027 * -17.5x
Enterprise Value 9.36B 10.7B 8.65B 7.96B 15B 1,031B 15.34B 103B 40.57B 505B 40.17B 39.3B 1,739B EV / Sales 2026 *
4.32x
EV / Sales 2027 * 4.9x
Free-Float
96.06%
Yield 2026 *
-
Yield 2027 * -
1 day-0.09%
1 week-0.01%
Current month-1.69%
1 month+0.65%
3 months-11.12%
6 months-16.07%
Current year-3.91%
1 week 88.35
Extreme 88.35
92.76
1 month 88.35
Extreme 88.35
98.81
Current year 79.52
Extreme 79.52
124
1 year 79.52
Extreme 79.52
124
3 years 76.53
Extreme 76.5301
131.49
5 years 76.53
Extreme 76.5301
464
10 years 12.52
Extreme 12.525
464
Manager TitleAgeSince
Chief Executive Officer 60 02/06/2008
Chief Tech/Sci/R&D Officer 59 01/01/2018
Director of Finance/CFO - 01/07/2025
Director TitleAgeSince
Director/Board Member 72 01/01/2022
Director/Board Member 69 02/06/2008
Director/Board Member 65 15/05/2026
Date Insider Type Main position Quantity % Market Cap.
12/5/26 Free

Chief Operating Officer

22,655 0.0094%
12/5/26 Free

Chief Financial Officer

33,982 0.0141%
12/5/26 Free

Head of Human Resources

18,879 0.0078%
Change 5-day change 1-year change 3-year change Capi.($)
-0.09%-0.01%-16.85%-15.41% 23.13B
+0.24%-1.54%+52.85%+71.85% 53.83B
-7.17%-4.39%+42.72%+73.32% 52.1B
+0.80%-6.31%+5.62%+417.78% 23.48B
-5.95%-2.58%+29.53%-9.47% 19.36B
-1.14%+0.03%+31.67%-30.65% 17.56B
-5.16%-7.00%+168.44%+314.96% 15.2B
-6.91%-5.83%+25.17%+644.30% 14.83B
+0.43%-1.03%+25.75%+189.74% 14.06B
+1.46%+3.13%+65.65%+152.36% 12.76B
Average -2.35%-2.05%+43.05%+180.88% 24.63B
Weighted average by Cap. -2.58%-2.07%+40.90%+143.61%

Financials

2026 *2027 *
Net sales 2.17B 2.48B 2B 1.84B 3.47B 239B 3.55B 23.89B 9.4B 117B 9.3B 9.1B 403B 2.23B 2.55B 2.06B 1.9B 3.57B 246B 3.65B 24.59B 9.67B 120B 9.57B 9.36B 414B
Net income -1.04B -1.19B -963M -886M -1.67B -115B -1.71B -11.49B -4.52B -56.22B -4.47B -4.37B -194B -1.16B -1.33B -1.08B -990M -1.87B -128B -1.91B -12.84B -5.05B -62.82B -5B -4.89B -216B
Net Debt -10.85B -12.4B -10.03B -9.22B -17.39B -1,195B -17.78B -120B -47.04B -586B -46.57B -45.56B -2,016B -9.29B -10.61B -8.58B -7.89B -14.88B -1,022B -15.21B -102B -40.24B -501B -39.84B -38.97B -1,724B
Logo BioNTech SE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Employees
7,807
Date Price Change Volume
17/07/26 USD 91.48 -0.09% 1,131,172
16/07/26 USD 91.56 -0.47% 670,293
15/07/26 USD 91.99 +1.76% 761,875
14/07/26 USD 90.40 +0.37% 923,470
13/07/26 USD 90.07 -1.55% 671,508
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
79.94EUR
Average target price
106.79EUR
Spread / Average Target
+33.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BNTX Stock